JFK UNIVERSITY MEDICAL CENTER — History
CCN 310108 | 3-year financial timeline | COVID resilience: 82/100
🛡️ Public data only — no PHI permitted on this instance.
$689M
Latest Revenue (FY2022)
+10.5%
Revenue CAGR (3yr)
-6.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $565M | $336M | $689M | +104.8% | +10.5% |
| Operating Expenses | $691M | $379M | $736M | +94.2% | +3.2% |
| Operating Margin | -22.3% | -12.7% | -6.8% | +46.1% | +0.0% |
| Net Income | $-126M | $-43M | $-47M | -10.4% | +0.0% |
| Licensed Beds | 344 | 349 | 351 | +0.6% | +1.0% |
| Total Patient Days | 96,064 | 48,094 | 98,800 | +105.4% | +1.4% |
| Medicare Day % | 33% | 30% | 31% | +2.1% | -2.3% |
| Medicaid Day % | 5% | 4% | 4% | +1.7% | -7.0% |
COVID Impact & Recovery
Resilience Score: 82/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +22.0% ($565M → $689M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+10.5%
This Hospital
+7.6%
State Avg
Latest Margin
-6.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $751M | 0.9% |
| FY2024 (proj) | $813M | 8.7% |
| FY2025 (proj) | $875M | 16.4% |